Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation

Pediatr Blood Cancer. 2023 Feb;70(2):e29928. doi: 10.1002/pbc.29928. Epub 2022 Aug 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cytoskeletal Proteins / genetics
  • Homozygote
  • Humans
  • Mutation
  • Spherocytosis, Hereditary* / genetics
  • Spherocytosis, Hereditary* / therapy

Substances

  • Cytoskeletal Proteins